Research visual

Health Research

One year follow-up of Medicare Advantage enrollees with type II diabetes and an initial elevated HbA1c value

Cordier T, Chiguluri V, Hines H et. al.  One year follow-up of Medicare Advantage patients with type 2 diabetes and an initial elevated HbA1c value.  Poster presentation.  American Diabetes Association Scientific Sessions.  June 25, 2018. Orlando, FL.

http://apps.humana.com/marketing/documents.asp?file=3341039

The importance of metabolic syndrome in patient progression to type 2 diabetes mellitus

Glasheen WP, Cordier T, Renda A et al. The importance of metabolic syndrome in patient progression to type 2 diabetes mellitus. Poster presentation at: American Diabetes Association Scientific Sessions. June 25, 2018. Orlando, FL.

http://apps.humana.com/marketing/documents.asp?file=3341026

Understanding the relationship between primary care provider (PCP) encounter cadence, medication adherence, and diabetes control

Wixson S, Dobbins J, Cordier T, Haugh G, Renda A, Happe L, Turchin A. Understanding the relationship between primary care provider (PCP) encounter cadence, medication adherence, and diabetes control. Poster presentation at: American Diabetes Association’s 78th Scientific Sessions, June 22-26, 2018 in Orlando, FL.

http://apps.humana.com/marketing/documents.asp?file=3335176

Virtual Diabetes Prevention Program: Effects on Medicare Advantage healthcare costs and utilization

Chiguluri V, Bartold D, Gumpina R, Castro Sweet C, Pieratt J, Cordier T, Matanich R, Renda A, Prewitt T. Virtual Diabetes Prevention Program: effects on Medicare Advantage healthcare costs and utilization. Poster presentation at American Diabetes Association Scientific Sessions. June 22-26, 2018. Orlando, FL.

http://apps.humana.com/marketing/documents.asp?file=3341013

Characteristics of patients with Medicare Advantage coverage and type II diabetes stratified by the presence of a foot ulcer or amputation

Chiguluri V, Gumpina R, Ganti M, Cordier T, Prewitt T, Weidenborner S, Gopal V. Characteristics of patients with Medicare Advantage coverage and type II diabetes stratified by the presence of a foot ulcer or amputation. Poster presented at: American Diabetes Association 77th Scientific Sessions. Jun 9-13, 2017. San Diego, CA.

http://apps.humana.com/marketing/documents.asp?file=3119012

Predictive model for diabetic foot wounds

Molu Shi, David Steenhard, Yanting Dong, Shannon Horsley, Todd Prewitt, Vipin Gopal. Predictive model for diabetic foot wounds. Poster presentation at: American Diabetes Association’s 77th Scientific Sessions. June 19-23, 2017. San Diego, CA.

http://apps.humana.com/marketing/documents.asp?file=3119688

Diabetes Complications Severity Index (DCSI) – update and ICD-10 translation

Glasheen WP,  Renda A, Dong Y. Diabetes Complications Severity Index (DCSI) – update and ICD-10 translation. J Diabetes Complications. 2017;31(6):1007-1013.

http://authors.elsevier.com/sd/article/S105687271631042X

Outcomes of a digital health program with human coaching for diabetes risk reduction in a Medicare population

Castro Sweet CM, Chiguluri V, Gumpina R, Abbott P, Madero EN, Payne M, Happe LE, Matanich R, Renda A, Prewitt T. Outcomes of a digital health program with human coaching for diabetes risk reduction in a Medicare population. J Aging Health. 2017; January 24. [Epub ahead of print].

http://journals.sagepub.com/doi/full/10.1177/0898264316688791

A predictive model for identifying individuals with diabetes at high risk of progression using Diabetes Complication Severity Index (DCSI)

Fan J, Dong Y, Chiguluri V, Glasheen W, Renda A, Prewitt T, Gopal V. A predictive model for identifying individuals with diabetes at high risk of progression using Diabetes Complication Severity Index. Diabetes 2016 Jun; 65(Supplement 1): A602.

Comparative effectiveness analysis of rapid-acting insulin therapies in a large national health plan

Rasca P, Meah Y, Ellis JJ, Saverno K. Comparative effectiveness analysis of rapid-acting insulin therapies in a large national health plan. J Manag Care Pharm. 2017:23(3):291-298.

https://www.ncbi.nlm.nih.gov/pubmed/?term=Comparative+effectiveness+of+rapid-acting+insulins+in+adults+with+diabete

Use of add-on treatment to metformin monotherapy for patients with type 2 diabetes and suboptimal glycemic control: a U.S. database study

Yu S, Schwab P, Bian B, Radican L, Tuncelli K. Use of add-on treatment to metformin monotherapy for patients with type 2 diabetes and suboptimal glycemic control: a U.S. database study. J Manag Care Spec Pharm. 2016;22(3):272-80.

http://www.jmcp.org/doi/pdf/10.18553/jmcp.2016.22.3.272

Early treatment revisions by addition or switch for type 2 diabetes: impact on glycemic control, diabetic complications, and healthcare costs

Schwab P, Saundankar V, Bouchard J, Wintfeld N, Suehs B, Moretz C, Allen E, DeLuzio A. Early treatment revisions by addition or switch for type 2 diabetes: impact on glycemic control, diabetic complications, and healthcare costs. BMJ Open Diabetes Research and Care 2016;4:e000099. doi:10.1136/bmjdrc-2015-000099

Early treatment revisions by addition or switch for type 2 diabetes: impact on glycemic control, diabetic complications,…

Variations in the rates of type 1 and type 2 diabetes in a managed care population stratified by age, geographic region, and insurance type

Slabaugh SL, Curtis B, Clore GS, et al. Variations in the rates of type 1 and type 2 diabetes in a managed care population stratified by age, geographic region, and insurance type. Poster presentation at: Academy of Managed Care Pharmacy 26th Annual Meeting and Expo. April 1-4, 2014; Tampa, FL.

http://apps.humana.com/marketing/documents.asp?file=2574572

Segmentation of a Medicare Advantage population using the Diabetes Complications Severity Index (DCSI)

Chiguluri V, Cusano D, Glasheen W, et al. Segmentation of a Medicare Advantage population using the Diabetes Complications Severity Index (DCSI). Poster presentation at: American Public Health Association 142nd Annual Meeting and Exposition. November 15-19, 2014; New Orleans, LA.

http://apps.humana.com/marketing/documents.asp?file=2645201

Retrospective cohort analysis of the patterns and predictors of metformin treatment change in a Medicare Advantage patient population from a large national health plan

Hazel-Fernandez L, Xu Y, Moretz C, et al. Retrospective cohort analysis of the patterns and predictors of metformin treatment change in a Medicare Advantage patient population from a large national health plan. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting. May 31-June 4, 2014; Montreal, QC, Canada.

http://apps.humana.com/marketing/documents.asp?file=2574507

Racial/ethnic and gender differences in severity of diabetes-related complications, healthcare resource use, and costs among Medicare Advantage recipients

Hazel-Fernandez L, Li Y, Nero D, et al. Racial/ethnic and gender differences in severity of diabetes-related complications, healthcare resource use, and costs among Medicare Advantage recipients. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting. May 31-June 4, 2014; Montreal, QC, Canada.

http://apps.humana.com/marketing/documents.asp?file=2574481

Potential drug-drug interactions and opioid use among painful diabetic peripheral neuropathy Medicare members newly started on pregabalin or duloxetine

Eyck LT, Sadosky A, Ellis J, et al. Potential drug-drug interactions and opioid use among painful diabetics peripheral neuropathy Medicare members newly started on pregablin or duloxetine. Poster presentation at: American Diabetes Association 74th Scientific Sessions. June 13-17, 2014; San Francisco, CA.

http://apps.humana.com/marketing/documents.asp?file=2574325

Heterogeneity of healthcare costs among Medicare Advantage patients with type 1 diabetes

Clore G, Slabaugh SL, Curtis BH, et al. Heterogeneity of healthcare costs among Medicare Advantage patients with type 1 diabetes. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting; May 31-June 4, 2014; Montreal, QC, Canada.

http://apps.humana.com/marketing/documents.asp?file=2573961

Factors associated with increased health care costs in Medicare Advantage patients with type 2 diabetes

Slabaugh SL, Curtis BH, Clore G, et al. Factors associated with increased health care costs in Medicare Advantage patients with type 2 diabetes. Poster presentation at: American Diabetes Association 74th scientific Sessions. June 13-17, 2014; San Francisco, CA.

http://apps.humana.com/marketing/documents.asp?file=2574052

Evaluation of association between diabetes related quality measure achievement and diabetes complications in a Medicare Advantage population

Ellis J, Bouchard J, Saundankar V, Moll K, et al. Evaluation of association between diabetes related quality measure achievement and diabetes complications in a Medicare Advantage population.  Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting. May 31-June 4, 2014; Montreal, QC, Canada.

http://apps.humana.com/marketing/documents.asp?file=2574026

Diabetes disease progression among a Medicare Advantage population - a retrospective analysis

Chiguluri V, Cusano D, Prewitt T, Gopal V, Painter P, Beveridge R. Diabetes disease progression among a Medicare Advantage population - a retrospective analysis. Poster presentation at: American Public Health Association 142nd Annual Meeting and Exposition. November 15-19, 2014; New Orleans, LA.

http://apps.humana.com/marketing/documents.asp?file=2379260

Delayed treatment modifications for patients with type 2 diabetes mellitus (T2DM) with very poor glycemic control

Schwab P, Saundankar V, Bouchard J, et al. Delayed treatment modifications for patients with type 2 diabetes mellitus (T2DM) with very poor glycemic control. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting. May 31-June 4, 2014; Montreal, QC, Canada.

http://apps.humana.com/marketing/documents.asp?file=2345278

Association between diabetes-related complications and healthcare resource use and costs in a large Medicare Advantage population

Hazel-Fernandez L. Association between diabetes-related complications and healthcare resource use and costs in a large Medicare Advantage population. Poster presentation at: American Diabetes Association's 73rd Scientific Sessions. June 21-25, 2013; Chicago, IL.

http://apps.humana.com/marketing/documents.asp?file=2573870

Analysis of a large payer claims database suggests elderly patients with diabetes are under-treated

Slabaugh SL, Yihua X, Stacy J, Patel N, Meah Y, Baltz J, Bouchard J. Analysis of a large payer claims database suggests elderly patients with diabetes are under-treated. Poster presentation at: American Diabetes Association 73rd Scientific Sessions. June 21-25, 2013; Chicago, IL.

http://apps.humana.com/marketing/documents.asp?file=2573818

Relationship between diabetes complications and health related quality of life among an elderly population in the United States

Chiguluri V, Guthikonda K, Slabaugh SL, Havens E, Pena J, Cordier T, Prewitt T, O'Connell K. Relationship between diabetes complications and health related quality of life among an elderly population in the United States. Poster Presentation at: American Diabetes Association 75th Scientific Session. June 5-9, 2015; Boston, MA.

http://apps.humana.com/marketing/documents.asp?file=2642081

Characteristics of and medication adherence for diabetic patients receiving dipeptidyl peptidase-4 inhibitors in the US Medicare and commercial insurance plans

Rascati K, Worley K, Meah Y, Everhart D. Characteristics of and medication adherence for diabetic patients receiving dipeptidyl peptidase-4 inhibitors in the US Medicare and commercial insurance plans. Poster presentation at: Academy of Managed Care Pharmacy Nexus Conference. October 26-29, 2015; Orlando, FL.

http://apps.humana.com/marketing/documents.asp?file=2799836

Costs for diabetic patients receiving dipeptidyl peptidase-4 (DPP-4) inhibitors in US Medicare and commercial insurance plans

Rascati KL, Worley K, Everhart D, Meah Y. Costs for diabetic patients receiving dipeptidyl peptidase-4 (DPP-4) inhibitors in US Medicare and commercial insurance plans. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 18th Annual European Congress. November 7-11, 2015; Milan, Italy.

http://apps.humana.com/marketing/documents.asp?file=2819232

Launching the CDC’s diabetes prevention program in a large employee population

Weaver L, Igleheart R, Radmacher M. Launching the CDC's diabetes prevention program in a large employee population. Poster presentation at: AcademyHealth Dissemination and Implementation. December 14-15, 2015; Washington, DC.

http://apps.humana.com/marketing/documents.asp?file=2826746

Differences in maintenance vs. acute care between a rural and urban Mississippi Medicare Advantage population with diabetes; a cross-sectional analysis

Majercak K, John P, Hettel C, Eaker E, Renda A, Cusano D, Gopal V. Differences in maintenance vs. acute care between a rural and urban Mississippi Medicare Advantage population with diabetes; a cross-sectional analysis. Podium presentation at: American Public Health Association 143rd Annual meeting and Expo. October 31 - November 4, 2015. Chicago IL.

http://apps.humana.com/marketing/documents.asp?file=2807623http://apps.humana.com/marketing/documents.asp?file=2856906

Call me maybe: lessons from recruitment strategies for a diabetes self-care program for a Medicare Advantage population

Radmacher M, Cordier T, Augspurger K, Haugh G, Gopal V. Call me maybe: lessons from recruitment strategies for a diabetes self-care program for a Medicare Advantage population. Podium presentation at: American Public Health Association 142nd Annual Meeting and Exposition. November, 2014; New Orleans, LA.

Facilitating access to free diabetic retinal exams with a novel geospatial approach in a national Medicare Advantage population with diabetes

Bae E, Kwong R, Augspurger K, Haugh G, Gopal V.  Facilitating access to free diabetic retinal exams with a novel geospatial approach in a national Medicare Advantage population with diabetes. Podium presentation at: American Public Health Association Annual Meeting and Exposition. November, 2014; New Orleans, LA.

Using electronic media to model appropriate diabetes-related health behaviors: a randomized trial of a DVD intervention

Hazel-Fernandez L. Using electronic media to model appropriate diabetes-related health behaviors: a randomized trial of a DVD intervention. Podium presentation at: Society of Behavioral Medicine Annual Meeting. April, 2009; Montreal, Canada.

The burden of diabetes mellitus for Medicare beneficiaries

Costantino ME, Stacy JN, Song F, Xu Y, Bouchard JR. The burden of diabetes mellitus for Medicare beneficiaries. Popul Health Manag. 2014;17(5):272-8.

The burden of diabetes mellitus for medicare beneficiaries. - PubMed - NCBI

Retrospective database analysis of the impact of prior authorization for type 2 diabetes medications on health care costs in a Medicare Advantage prescription drug plan population

Bergeson JG, Worley K, Louder A, Ward M, Graham J. Retrospective database analysis of the impact of prior authorization for Type 2 Diabetes medications on health care costs in a Medicare Advantage Prescription Drug Plan population. J Manag Care Pharm.2013;19(5):374-84.

Retrospective database analysis of the impact of prior authorization for type 2 diabetes medications on health care cost…

Resource utilization and health care costs among diabetics with urinary tract infections in a commercially insured population

Worley K, Bell KF, Xu Y, Parasuraman S, Graham J. Resource utilization and health care costs among diabetics with urinary tract infections in a commercially insured population. J Clin Outcomes Mang. 2012;19(12):539-50.

Health economics perspective of the components of the cardiometabolic syndrome

Tamariz L, Palacio A, Yang T, Parris D, Ben-Joseph R, Florez H. Health economics perspective of the components of the cardiometabolic syndrome. J Clin Hypertens. 2010;12(7):549-55.

Health economics perspective of the components of the cardiometabolic syndrome. - PubMed - NCBI

Factors associated with increased healthcare costs in Medicare Advantage patients with type 2 diabetes enrolled in a large representative health insurance plan in the United States

Slabaugh SL, Curtis BH, Clore G, et al.  Factors associated with increased healthcare costs in Medicare Advantage patients with type 2 diabetes enrolled in a large representative health insurance plan in the United States. J Med Econ. 2015;18(2):106-12.

Factors associated with increased healthcare costs in Medicare Advantage patients with type 2 diabetes enrolled in a lar…

A relationship of diabetes complications severity to healthcare utilization and costs among Medicare Advantage beneficiaries

Hazel-Fernandez L, Li Y, Nero D, et al. A relationship of diabetes complications severity to healthcare utilization and costs among Medicare Advantage beneficiaries.  Am J Manag Care. 2015;21(1):e62-70.

Relationship of diabetes complications severity to healthcare utilization and costs among Medicare Advantage beneficiari…

Two randomized controlled pilot trials of social forces to improve statin adherence among patients with diabetes

Reese PP, Kessler JB, Doshi JA, et al. Two randomized controlled pilot trials of social forces to improve statin adherence among patients with diabetes. J Gen Intern Med. 2016;31(4):402-10.

http://www.ncbi.nlm.nih.gov/pubmed/26585957

Using sequence discovery to target outreach for diabetes medication adherence

Lopez A, Long CL, Happe LE, Relish M. Using sequence discovery to target outreach for diabetes medication adherence. Am J Manag Care. 2015;21(11):e601-e608

Using sequence discovery to target outreach for diabetes medication adherence. - PubMed - NCBI

One year follow-up of Medicare Advantage enrollees with type II diabetes and an initial elevated HbA1c value

Cordier T, Chiguluri V, Hines H et. al.  One year follow-up of Medicare Advantage patients with type 2 diabetes and an initial elevated HbA1c value.  Poster presentation.  American Diabetes Association Scientific Sessions.  June 25, 2018. Orlando, FL.

http://apps.humana.com/marketing/documents.asp?file=3341039

The importance of metabolic syndrome in patient progression to type 2 diabetes mellitus

Glasheen WP, Cordier T, Renda A et al. The importance of metabolic syndrome in patient progression to type 2 diabetes mellitus. Poster presentation at: American Diabetes Association Scientific Sessions. June 25, 2018. Orlando, FL.

http://apps.humana.com/marketing/documents.asp?file=3341026

Understanding the relationship between primary care provider (PCP) encounter cadence, medication adherence, and diabetes control

Wixson S, Dobbins J, Cordier T, Haugh G, Renda A, Happe L, Turchin A. Understanding the relationship between primary care provider (PCP) encounter cadence, medication adherence, and diabetes control. Poster presentation at: American Diabetes Association’s 78th Scientific Sessions, June 22-26, 2018 in Orlando, FL.

http://apps.humana.com/marketing/documents.asp?file=3335176

Virtual Diabetes Prevention Program: Effects on Medicare Advantage healthcare costs and utilization

Chiguluri V, Bartold D, Gumpina R, Castro Sweet C, Pieratt J, Cordier T, Matanich R, Renda A, Prewitt T. Virtual Diabetes Prevention Program: effects on Medicare Advantage healthcare costs and utilization. Poster presentation at American Diabetes Association Scientific Sessions. June 22-26, 2018. Orlando, FL.

http://apps.humana.com/marketing/documents.asp?file=3341013

Characteristics of patients with Medicare Advantage coverage and type II diabetes stratified by the presence of a foot ulcer or amputation

Chiguluri V, Gumpina R, Ganti M, Cordier T, Prewitt T, Weidenborner S, Gopal V. Characteristics of patients with Medicare Advantage coverage and type II diabetes stratified by the presence of a foot ulcer or amputation. Poster presented at: American Diabetes Association 77th Scientific Sessions. Jun 9-13, 2017. San Diego, CA.

http://apps.humana.com/marketing/documents.asp?file=3119012

Predictive model for diabetic foot wounds

Molu Shi, David Steenhard, Yanting Dong, Shannon Horsley, Todd Prewitt, Vipin Gopal. Predictive model for diabetic foot wounds. Poster presentation at: American Diabetes Association’s 77th Scientific Sessions. June 19-23, 2017. San Diego, CA.

http://apps.humana.com/marketing/documents.asp?file=3119688

Diabetes Complications Severity Index (DCSI) – update and ICD-10 translation

Glasheen WP,  Renda A, Dong Y. Diabetes Complications Severity Index (DCSI) – update and ICD-10 translation. J Diabetes Complications. 2017;31(6):1007-1013.

http://authors.elsevier.com/sd/article/S105687271631042X

Outcomes of a digital health program with human coaching for diabetes risk reduction in a Medicare population

Castro Sweet CM, Chiguluri V, Gumpina R, Abbott P, Madero EN, Payne M, Happe LE, Matanich R, Renda A, Prewitt T. Outcomes of a digital health program with human coaching for diabetes risk reduction in a Medicare population. J Aging Health. 2017; January 24. [Epub ahead of print].

http://journals.sagepub.com/doi/full/10.1177/0898264316688791

A predictive model for identifying individuals with diabetes at high risk of progression using Diabetes Complication Severity Index (DCSI)

Fan J, Dong Y, Chiguluri V, Glasheen W, Renda A, Prewitt T, Gopal V. A predictive model for identifying individuals with diabetes at high risk of progression using Diabetes Complication Severity Index. Diabetes 2016 Jun; 65(Supplement 1): A602.

Comparative effectiveness analysis of rapid-acting insulin therapies in a large national health plan

Rasca P, Meah Y, Ellis JJ, Saverno K. Comparative effectiveness analysis of rapid-acting insulin therapies in a large national health plan. J Manag Care Pharm. 2017:23(3):291-298.

https://www.ncbi.nlm.nih.gov/pubmed/?term=Comparative+effectiveness+of+rapid-acting+insulins+in+adults+with+diabete

Use of add-on treatment to metformin monotherapy for patients with type 2 diabetes and suboptimal glycemic control: a U.S. database study

Yu S, Schwab P, Bian B, Radican L, Tuncelli K. Use of add-on treatment to metformin monotherapy for patients with type 2 diabetes and suboptimal glycemic control: a U.S. database study. J Manag Care Spec Pharm. 2016;22(3):272-80.

http://www.jmcp.org/doi/pdf/10.18553/jmcp.2016.22.3.272

Early treatment revisions by addition or switch for type 2 diabetes: impact on glycemic control, diabetic complications, and healthcare costs

Schwab P, Saundankar V, Bouchard J, Wintfeld N, Suehs B, Moretz C, Allen E, DeLuzio A. Early treatment revisions by addition or switch for type 2 diabetes: impact on glycemic control, diabetic complications, and healthcare costs. BMJ Open Diabetes Research and Care 2016;4:e000099. doi:10.1136/bmjdrc-2015-000099

Early treatment revisions by addition or switch for type 2 diabetes: impact on glycemic control, diabetic complications,…

Variations in the rates of type 1 and type 2 diabetes in a managed care population stratified by age, geographic region, and insurance type

Slabaugh SL, Curtis B, Clore GS, et al. Variations in the rates of type 1 and type 2 diabetes in a managed care population stratified by age, geographic region, and insurance type. Poster presentation at: Academy of Managed Care Pharmacy 26th Annual Meeting and Expo. April 1-4, 2014; Tampa, FL.

http://apps.humana.com/marketing/documents.asp?file=2574572

Segmentation of a Medicare Advantage population using the Diabetes Complications Severity Index (DCSI)

Chiguluri V, Cusano D, Glasheen W, et al. Segmentation of a Medicare Advantage population using the Diabetes Complications Severity Index (DCSI). Poster presentation at: American Public Health Association 142nd Annual Meeting and Exposition. November 15-19, 2014; New Orleans, LA.

http://apps.humana.com/marketing/documents.asp?file=2645201

Retrospective cohort analysis of the patterns and predictors of metformin treatment change in a Medicare Advantage patient population from a large national health plan

Hazel-Fernandez L, Xu Y, Moretz C, et al. Retrospective cohort analysis of the patterns and predictors of metformin treatment change in a Medicare Advantage patient population from a large national health plan. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting. May 31-June 4, 2014; Montreal, QC, Canada.

http://apps.humana.com/marketing/documents.asp?file=2574507

Racial/ethnic and gender differences in severity of diabetes-related complications, healthcare resource use, and costs among Medicare Advantage recipients

Hazel-Fernandez L, Li Y, Nero D, et al. Racial/ethnic and gender differences in severity of diabetes-related complications, healthcare resource use, and costs among Medicare Advantage recipients. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting. May 31-June 4, 2014; Montreal, QC, Canada.

http://apps.humana.com/marketing/documents.asp?file=2574481

Potential drug-drug interactions and opioid use among painful diabetic peripheral neuropathy Medicare members newly started on pregabalin or duloxetine

Eyck LT, Sadosky A, Ellis J, et al. Potential drug-drug interactions and opioid use among painful diabetics peripheral neuropathy Medicare members newly started on pregablin or duloxetine. Poster presentation at: American Diabetes Association 74th Scientific Sessions. June 13-17, 2014; San Francisco, CA.

http://apps.humana.com/marketing/documents.asp?file=2574325

Heterogeneity of healthcare costs among Medicare Advantage patients with type 1 diabetes

Clore G, Slabaugh SL, Curtis BH, et al. Heterogeneity of healthcare costs among Medicare Advantage patients with type 1 diabetes. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting; May 31-June 4, 2014; Montreal, QC, Canada.

http://apps.humana.com/marketing/documents.asp?file=2573961

Factors associated with increased health care costs in Medicare Advantage patients with type 2 diabetes

Slabaugh SL, Curtis BH, Clore G, et al. Factors associated with increased health care costs in Medicare Advantage patients with type 2 diabetes. Poster presentation at: American Diabetes Association 74th scientific Sessions. June 13-17, 2014; San Francisco, CA.

http://apps.humana.com/marketing/documents.asp?file=2574052

Evaluation of association between diabetes related quality measure achievement and diabetes complications in a Medicare Advantage population

Ellis J, Bouchard J, Saundankar V, Moll K, et al. Evaluation of association between diabetes related quality measure achievement and diabetes complications in a Medicare Advantage population.  Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting. May 31-June 4, 2014; Montreal, QC, Canada.

http://apps.humana.com/marketing/documents.asp?file=2574026

Diabetes disease progression among a Medicare Advantage population - a retrospective analysis

Chiguluri V, Cusano D, Prewitt T, Gopal V, Painter P, Beveridge R. Diabetes disease progression among a Medicare Advantage population - a retrospective analysis. Poster presentation at: American Public Health Association 142nd Annual Meeting and Exposition. November 15-19, 2014; New Orleans, LA.

http://apps.humana.com/marketing/documents.asp?file=2379260

Delayed treatment modifications for patients with type 2 diabetes mellitus (T2DM) with very poor glycemic control

Schwab P, Saundankar V, Bouchard J, et al. Delayed treatment modifications for patients with type 2 diabetes mellitus (T2DM) with very poor glycemic control. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting. May 31-June 4, 2014; Montreal, QC, Canada.

http://apps.humana.com/marketing/documents.asp?file=2345278

Association between diabetes-related complications and healthcare resource use and costs in a large Medicare Advantage population

Hazel-Fernandez L. Association between diabetes-related complications and healthcare resource use and costs in a large Medicare Advantage population. Poster presentation at: American Diabetes Association's 73rd Scientific Sessions. June 21-25, 2013; Chicago, IL.

http://apps.humana.com/marketing/documents.asp?file=2573870

Analysis of a large payer claims database suggests elderly patients with diabetes are under-treated

Slabaugh SL, Yihua X, Stacy J, Patel N, Meah Y, Baltz J, Bouchard J. Analysis of a large payer claims database suggests elderly patients with diabetes are under-treated. Poster presentation at: American Diabetes Association 73rd Scientific Sessions. June 21-25, 2013; Chicago, IL.

http://apps.humana.com/marketing/documents.asp?file=2573818

Relationship between diabetes complications and health related quality of life among an elderly population in the United States

Chiguluri V, Guthikonda K, Slabaugh SL, Havens E, Pena J, Cordier T, Prewitt T, O'Connell K. Relationship between diabetes complications and health related quality of life among an elderly population in the United States. Poster Presentation at: American Diabetes Association 75th Scientific Session. June 5-9, 2015; Boston, MA.

http://apps.humana.com/marketing/documents.asp?file=2642081

Characteristics of and medication adherence for diabetic patients receiving dipeptidyl peptidase-4 inhibitors in the US Medicare and commercial insurance plans

Rascati K, Worley K, Meah Y, Everhart D. Characteristics of and medication adherence for diabetic patients receiving dipeptidyl peptidase-4 inhibitors in the US Medicare and commercial insurance plans. Poster presentation at: Academy of Managed Care Pharmacy Nexus Conference. October 26-29, 2015; Orlando, FL.

http://apps.humana.com/marketing/documents.asp?file=2799836

Costs for diabetic patients receiving dipeptidyl peptidase-4 (DPP-4) inhibitors in US Medicare and commercial insurance plans

Rascati KL, Worley K, Everhart D, Meah Y. Costs for diabetic patients receiving dipeptidyl peptidase-4 (DPP-4) inhibitors in US Medicare and commercial insurance plans. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 18th Annual European Congress. November 7-11, 2015; Milan, Italy.

http://apps.humana.com/marketing/documents.asp?file=2819232

Launching the CDC’s diabetes prevention program in a large employee population

Weaver L, Igleheart R, Radmacher M. Launching the CDC's diabetes prevention program in a large employee population. Poster presentation at: AcademyHealth Dissemination and Implementation. December 14-15, 2015; Washington, DC.

http://apps.humana.com/marketing/documents.asp?file=2826746

Differences in maintenance vs. acute care between a rural and urban Mississippi Medicare Advantage population with diabetes; a cross-sectional analysis

Majercak K, John P, Hettel C, Eaker E, Renda A, Cusano D, Gopal V. Differences in maintenance vs. acute care between a rural and urban Mississippi Medicare Advantage population with diabetes; a cross-sectional analysis. Podium presentation at: American Public Health Association 143rd Annual meeting and Expo. October 31 - November 4, 2015. Chicago IL.

http://apps.humana.com/marketing/documents.asp?file=2807623http://apps.humana.com/marketing/documents.asp?file=2856906

Call me maybe: lessons from recruitment strategies for a diabetes self-care program for a Medicare Advantage population

Radmacher M, Cordier T, Augspurger K, Haugh G, Gopal V. Call me maybe: lessons from recruitment strategies for a diabetes self-care program for a Medicare Advantage population. Podium presentation at: American Public Health Association 142nd Annual Meeting and Exposition. November, 2014; New Orleans, LA.

Facilitating access to free diabetic retinal exams with a novel geospatial approach in a national Medicare Advantage population with diabetes

Bae E, Kwong R, Augspurger K, Haugh G, Gopal V.  Facilitating access to free diabetic retinal exams with a novel geospatial approach in a national Medicare Advantage population with diabetes. Podium presentation at: American Public Health Association Annual Meeting and Exposition. November, 2014; New Orleans, LA.

Using electronic media to model appropriate diabetes-related health behaviors: a randomized trial of a DVD intervention

Hazel-Fernandez L. Using electronic media to model appropriate diabetes-related health behaviors: a randomized trial of a DVD intervention. Podium presentation at: Society of Behavioral Medicine Annual Meeting. April, 2009; Montreal, Canada.

The burden of diabetes mellitus for Medicare beneficiaries

Costantino ME, Stacy JN, Song F, Xu Y, Bouchard JR. The burden of diabetes mellitus for Medicare beneficiaries. Popul Health Manag. 2014;17(5):272-8.

The burden of diabetes mellitus for medicare beneficiaries. - PubMed - NCBI

Retrospective database analysis of the impact of prior authorization for type 2 diabetes medications on health care costs in a Medicare Advantage prescription drug plan population

Bergeson JG, Worley K, Louder A, Ward M, Graham J. Retrospective database analysis of the impact of prior authorization for Type 2 Diabetes medications on health care costs in a Medicare Advantage Prescription Drug Plan population. J Manag Care Pharm.2013;19(5):374-84.

Retrospective database analysis of the impact of prior authorization for type 2 diabetes medications on health care cost…

Resource utilization and health care costs among diabetics with urinary tract infections in a commercially insured population

Worley K, Bell KF, Xu Y, Parasuraman S, Graham J. Resource utilization and health care costs among diabetics with urinary tract infections in a commercially insured population. J Clin Outcomes Mang. 2012;19(12):539-50.

Health economics perspective of the components of the cardiometabolic syndrome

Tamariz L, Palacio A, Yang T, Parris D, Ben-Joseph R, Florez H. Health economics perspective of the components of the cardiometabolic syndrome. J Clin Hypertens. 2010;12(7):549-55.

Health economics perspective of the components of the cardiometabolic syndrome. - PubMed - NCBI

Factors associated with increased healthcare costs in Medicare Advantage patients with type 2 diabetes enrolled in a large representative health insurance plan in the United States

Slabaugh SL, Curtis BH, Clore G, et al.  Factors associated with increased healthcare costs in Medicare Advantage patients with type 2 diabetes enrolled in a large representative health insurance plan in the United States. J Med Econ. 2015;18(2):106-12.

Factors associated with increased healthcare costs in Medicare Advantage patients with type 2 diabetes enrolled in a lar…

A relationship of diabetes complications severity to healthcare utilization and costs among Medicare Advantage beneficiaries

Hazel-Fernandez L, Li Y, Nero D, et al. A relationship of diabetes complications severity to healthcare utilization and costs among Medicare Advantage beneficiaries.  Am J Manag Care. 2015;21(1):e62-70.

Relationship of diabetes complications severity to healthcare utilization and costs among Medicare Advantage beneficiari…

Two randomized controlled pilot trials of social forces to improve statin adherence among patients with diabetes

Reese PP, Kessler JB, Doshi JA, et al. Two randomized controlled pilot trials of social forces to improve statin adherence among patients with diabetes. J Gen Intern Med. 2016;31(4):402-10.

http://www.ncbi.nlm.nih.gov/pubmed/26585957

Using sequence discovery to target outreach for diabetes medication adherence

Lopez A, Long CL, Happe LE, Relish M. Using sequence discovery to target outreach for diabetes medication adherence. Am J Manag Care. 2015;21(11):e601-e608

Using sequence discovery to target outreach for diabetes medication adherence. - PubMed - NCBI